Research
PROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug Discovery
How PROTACs and molecular glues are redefining drug discovery through targeted protein degradation strategies.
Mrudula Kulkarni | Feb 13, 2026
20260213135839.webp)
Research
Neuroinflammation As A Target Class: The New Frontier In CNS Drug Development
Why neuroinflammation is emerging as a major target class reshaping CNS drug development and neurology research.
Vaibhavi M. | Feb 13, 2026
Research
Senolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing
How senolytics and microbiome modifiers are reshaping ageing biology by targeting inflammation, senescence, and system-level decline.
Mrudula Kulkarni | Feb 12, 2026
20260212173840.webp)
Research
Psychedelic-Assisted Therapies: How Science Is Re-Exploring A Controversial Class Of Medicines
How psychedelic-assisted therapies are being re-explored to treat depression, PTSD, and addiction through science-led care.
Vaibhavi M. | Feb 12, 2026
Innovation
Live Biotherapeutic Products: The Future of Microbiome-Based Medicine
A deep dive into the clinical development, safety considerations, and commercial future of live biotherapeutic products.
Vaibhavi M. | Jan 27, 2026
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news